Author:
Mikami Mikio,Tanabe Kazuhiro,Imanishi Tadashi,Ikeda Masae,Hirasawa Takeshi,Yasaka Miwa,Machida Hiroko,Yoshida Hiroshi,Hasegawa Masanori,Shimada Muneaki,Kato Tomoyasu,Kitamura Shoichi,Kato Hisamori,Fujii Takuma,Kobayashi Yoichi,Suzuki Nao,Tanaka Kyoko,Murakami Isao,Katahira Tomoko,Hayashi Chihiro,Matsuo Koji
Funder
Ministry of Education, Culture, Sports, Science and Technology
Japan Agency for Medical Research and Development
Minoru Sano Memorial Fund, Japan
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA: Cancer J. Clin. 73, 17–48 (2023).
2. Cronin, K. A. et al. Annual report to the nation on the status of cancer, part 1: National cancer statistics. Cancer 128, 4251–4284 (2022).
3. Cancer Research UK, Ovarian cancer survival statistics, https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/survival, accessed on Feb. 14, 2023.
4. Khiewvan, B. et al. An update on the role of PET/CT and PET/MRI in ovarian cancer. Eur. J. Nuclear Med. Mol. Imaging 44, 1079–1091 (2017).
5. Sironi, S. et al. Integrated FDG PET/CT in patients with persistent ovarian cancer: Correlation with histologic findings. Radiology 233, 433–440 (2004).